{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:11:40Z","timestamp":1788783100728,"version":"build-2803163510"},"reference-count":40,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100020107","name":"Hirose Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23H03739"],"award-info":[{"award-number":["23H03739"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005623","name":"University of Tokushima","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005623","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Polyethylene glycol (PEG) is widely utilized in pharmaceuticals and cosmetics as a safe and less- or nonimmunogenic synthesized biocompatible polymer. However, the increasing detection of pre-existing anti-PEG antibodies in untreated individuals has raised concerns that daily exposure to PEG derivatives through cosmetics could induce immune responses against PEG. We have shown that daily topical applications of this type of cosmetic product cause anti-PEG IgM production in normal mice, and the efficacy of PEGylated therapeutics was suppressed by this induced anti-PEG IgM. In this study, the mechanism underlying anti-PEG IgM production caused by topical applications of a cosmetic product containing PEG derivatives, which are yet to be identified, was investigated in mice. Daily applications of such a cosmetic product to the compromised skin of mice elicited anti-PEG IgM production. Splenectomy, performed before the topical applications, markedly suppressed the anti-PEG response. In addition, when splenectomy was carried out after 14 days of daily topical applications, there was a remarkable decline in the anti-PEG IgM response that had already been induced. In this study, however, splenectomy completely diminished neither anti-PEG IgM production nor pre-existing anti-PEG IgM titers. Although immunodeficient C.B-17\/Icr-scid\/scid (SCID) mice caused no anti-PEG IgM production, the adoptive transfer of splenocytes obtained from normal mice to SCID mice restored the anti-PEG response to daily topical applications of this cosmetic product. Furthermore, anti-PEG IgM production was observed in T cell-deficient BALB\/cAJcl-nu\/nu (BALB\/c-nu) mice. In the lymph node-deficient ALY\/NscJcl-aly\/aly (aly\/aly) mice, daily topical applications of this cosmetic product also caused anti-PEG IgM production, but the titer was lower than that in normal mice. The results of this study show the spleen to be the primary contributor, while lymph nodes play a partial role, in the production of anti-PEG IgM via daily topical applications of this cosmetic product in a T cell-independent manner in mice. This study provides mechanistic insight into how daily topical exposure to PEG could lead to the formation of pre-existing anti-PEG IgM, which in turn would alter the pharmacokinetics and therapeutic efficacy of PEGylated therapeutics.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6c00395","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:39:41Z","timestamp":1785854381000},"page":"4673-4680","source":"Crossref","is-referenced-by-count":0,"title":["A Cosmetic\nProduct Containing PEG Derivatives Induces\nAnti-PEG IgM Mainly through Stimulation of the Spleen Cells in Mice"],"prefix":"10.1021","volume":"23","author":[{"given":"Yuri","family":"Kim","sequence":"first","affiliation":[{"name":"Tokushima University , , 1-78-1, Sho-machi , ,","place":["Tokushima, Japan, 770-8505"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Takata","sequence":"additional","affiliation":[{"name":"Tokushima University , , 1-78-1, Sho-machi , ,","place":["Tokushima, Japan, 770-8505"]},{"name":"Tokushima University , , ,","place":["Tokushima, Japan, 770-8505"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8357-8654","authenticated-orcid":true,"given":"Shingo","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Tokushima University , , 1-78-1, Sho-machi , ,","place":["Tokushima, Japan, 770-8505"]},{"name":"Tokushima University , , ,","place":["Tokushima, Japan, 770-8505"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-7574","authenticated-orcid":true,"given":"Hidenori","family":"Ando","sequence":"additional","affiliation":[{"name":"Tokushima University , , 1-78-1, Sho-machi , ,","place":["Tokushima, Japan, 770-8505"]},{"name":"Tokushima University , , ,","place":["Tokushima, Japan, 770-8505"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1333-6465","authenticated-orcid":true,"given":"Tatsuhiro","family":"Ishida","sequence":"additional","affiliation":[{"name":"Tokushima University , , 1-78-1, Sho-machi , ,","place":["Tokushima, Japan, 770-8505"]},{"name":"Tokushima University , , ,","place":["Tokushima, Japan, 770-8505"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"2026090707075315700_cit1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0005-2736(91)90201-I","article-title":"Pharmacokinetics of stealth versus conventional liposomes:\neffect of dose","volume":"1068","author":"Allen","year":"1991","journal-title":"Biochim. Biophys. Acta, Biomembr."},{"key":"2026090707075315700_cit2","doi-asserted-by":"publisher","first-page":"11460","DOI":"10.1073\/pnas.88.24.11460","article-title":"Sterically\nstabilized liposomes: improvements\nin pharmacokinetics and antitumor therapeutic efficacy","volume":"88","author":"Papahadjopoulos","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026090707075315700_cit3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","article-title":"Amphipathic polyethyleneglycols\neffectively prolong the circulation time of liposomes","volume":"268","author":"Klibanov","year":"1990","journal-title":"FEBS Lett."},{"key":"2026090707075315700_cit4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2165\/00003088-200140070-00005","article-title":"Pegylation: a novel\nprocess for modifying\npharmacokinetics","volume":"40","author":"Harris","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"2026090707075315700_cit5","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful\napproach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discovery Today"},{"key":"2026090707075315700_cit6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5487\/TR.2015.31.2.105","article-title":"Safety\nEvaluation of Polyethylene\nGlycol (PEG) Compounds for Cosmetic Use","volume":"31","author":"Jang","year":"2015","journal-title":"Toxicol.\nRes."},{"key":"2026090707075315700_cit7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/17425240802650568","article-title":"PEG-modified biopharmaceuticals","volume":"6","author":"Bailon","year":"2009","journal-title":"Expert Opin. Drug Delivery"},{"key":"2026090707075315700_cit8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jconrel.2007.05.015","article-title":"PEGylated\nliposomes elicit an anti-PEG IgM response in a T cell-independent\nmanner","volume":"122","author":"Ishida","year":"2007","journal-title":"J. Controlled Release"},{"key":"2026090707075315700_cit9","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated blood\nclearance and altered biodistribution of repeated injections of sterically\nstabilized liposomes","volume":"292","author":"Dams","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026090707075315700_cit10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1021\/acs.molpharmaceut.3c00774","article-title":"Impact of Anti-PEG\nIgM Induced via the Topical Application of a Cosmetic Product Containing\nPEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor\nDrug Formulations in Mice","volume":"21","author":"Gaballa","year":"2024","journal-title":"Mol. Pharmaceutics"},{"issue":"1","key":"2026090707075315700_cit11","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00766-z","article-title":"Polyethylene glycol (PEG)-associated\nimmune responses triggered by clinically relevant lipid nanoparticles\nin rats","volume":"8","author":"Wang","year":"2023","journal-title":"NPJ. Vaccines"},{"key":"2026090707075315700_cit12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0022-3565(24)29419-2","article-title":"Factors affecting\nthe\naccelerated blood clearance of polyethylene glycol-liposomes upon\nrepeated injection","volume":"298","author":"Laverman","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026090707075315700_cit13","first-page":"286","article-title":"The accelerated clearance\non repeated injection of pegylated liposomes in rats: laboratory and\nhistopathological study","volume":"7","author":"Ishida","year":"2002","journal-title":"Cell Mol. Biol. Lett."},{"key":"2026090707075315700_cit14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0168-3659(02)00462-5","article-title":"Accelerated\nclearance of PEGylated liposomes in rats after repeated injections","volume":"88","author":"Ishida","year":"2003","journal-title":"J. Controlled Release"},{"key":"2026090707075315700_cit15","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1517\/17425247.2012.720969","article-title":"Antibodies\nagainst polyethylene glycol in healthy subjects and in patients treated\nwith PEG-conjugated agents","volume":"9","author":"Garay","year":"2012","journal-title":"Expert Opin. Drug\nDelivery"},{"key":"2026090707075315700_cit16","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s11095-016-1961-x","article-title":"The Mystery of Antibodies Against\nPolyethylene Glycol (PEG) - What do we Know?","volume":"33","author":"Lubich","year":"2016","journal-title":"Pharm. Res."},{"key":"2026090707075315700_cit17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.toxrep.2020.12.022","article-title":"Flow cytometry analysis\nof anti-polyethylene glycol antibodies in human plasma","volume":"8","author":"Fang","year":"2021","journal-title":"Toxicol. Rep."},{"key":"2026090707075315700_cit18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jconrel.2023.01.012","article-title":"Investigation\nof anti-PEG\nantibody response to PEG-containing cosmetic products in mice","volume":"354","author":"Ibrahim","year":"2023","journal-title":"J. Controlled Release"},{"key":"2026090707075315700_cit19","doi-asserted-by":"publisher","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG antibodies boosted in humans\nby SARS-CoV-2 lipid nanoparticle mRNA vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"key":"2026090707075315700_cit20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41577-022-00825-x","article-title":"Impact\nof anti-PEG antibodies induced by SARS-CoV-2\nmRNA vaccines","volume":"23","author":"Ju","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"2026090707075315700_cit21","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c11652","article-title":"Blood distribution\nof SARS-CoV-2 lipid nanoparticle mRNA vaccine\nin humans","volume":"18","author":"Kent","year":"2024","journal-title":"ACS Nano"},{"key":"2026090707075315700_cit22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrd1775","article-title":"Design and development\nof polymers for gene delivery","volume":"4","author":"Pack","year":"2005","journal-title":"Nat. Rev. Drug\nDiscovery"},{"key":"2026090707075315700_cit23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jconrel.2007.02.010","article-title":"Anti-PEG IgM\nelicited by injection\nof liposomes is involved in the enhanced blood clearance of a subsequent\ndose of PEGylated liposomes","volume":"119","author":"Wang","year":"2007","journal-title":"J. Controlled Release"},{"key":"2026090707075315700_cit24","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.drudis.2014.08.015","article-title":"Potential\ninduction of anti-PEG antibodies and complement activation toward\nPEGylated therapeutics","volume":"19","author":"Verhoef","year":"2014","journal-title":"Drug Discovery Today"},{"key":"2026090707075315700_cit25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev.me.37.020186.000405","article-title":"The role of the\nspleen in resistance to infection","volume":"37","author":"Bohnsack","year":"1986","journal-title":"Annu. Rev.\nMed."},{"key":"2026090707075315700_cit26","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.4049\/jimmunol.128.4.1497","article-title":"The capacity and mechanism\nof bone marrow antibody formation by thymus-independent antigens","volume":"128","author":"Koch","year":"1982","journal-title":"J. Immunol"},{"key":"2026090707075315700_cit27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.imbio.2012.08.274","article-title":"Transport of PEGylated\nliposomes\nfrom the splenic marginal zone to the follicle in the induction phase\nof the accelerated blood clearance phenomenon","volume":"218","author":"Shimizu","year":"2013","journal-title":"Immunobiology"},{"key":"2026090707075315700_cit28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1248\/bpb.b14-00653","article-title":"Relationship\nbetween the concentration of anti-polyethylene glycol (PEG) immunoglobulin\nM (IgM) and the intensity of the accelerated blood clearance (ABC)\nphenomenon against PEGylated liposomes in mice","volume":"38","author":"Hashimoto","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"2026090707075315700_cit29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijpharm.2010.03.022","article-title":"T cell-independent B cell response is responsible for ABC phenomenon\ninduced by repeated injection of PEGylated liposomes","volume":"392","author":"Koide","year":"2010","journal-title":"Int. J. Pharm."},{"key":"2026090707075315700_cit30","doi-asserted-by":"publisher","first-page":"7198","DOI":"10.4049\/jimmunol.162.12.7198","article-title":"IgMhighCD21high\nlymphocytes enriched\nin the splenic marginal zone generate effector cells more rapidly\nthan the bulk of follicular B cells","volume":"162","author":"Oliver","year":"1999","journal-title":"J. Immunol."},{"key":"2026090707075315700_cit31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0021-9258(18)70227-5","article-title":"Colorimetric\nassay methods for free and phosphorylated glyceric acids","volume":"234","author":"Bartlett","year":"1959","journal-title":"J. Biol. Chem."},{"key":"2026090707075315700_cit32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics3010001","article-title":"Anti-PEG IgM Response\nagainst PEGylated Liposomes in Mice and Rats","volume":"3","author":"Ichihara","year":"2011","journal-title":"Pharmaceutics"},{"key":"2026090707075315700_cit33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jconrel.2006.01.005","article-title":"Injection of PEGylated liposomes\nin rats elicits PEG-specific IgM, which is responsible for rapid elimination\nof a second dose of PEGylated liposomes","volume":"112","author":"Ishida","year":"2006","journal-title":"J.\nControlled Release"},{"key":"2026090707075315700_cit34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/eji.1830240224","article-title":"A new mutation, aly,\nthat induces\na generalized lack of lymph nodes accompanied by immunodeficiency\nin mice","volume":"24","author":"Miyawaki","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"2026090707075315700_cit35","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1002\/eji.1830261129","article-title":"Autoimmune\ndisease of exocrine organs\nin immunodeficient alymphoplasia mice: a spontaneous model for Sjogren\u2019s\nsyndrome","volume":"26","author":"Tsubata","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"2026090707075315700_cit36","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/intimm\/8.7.1067","article-title":"Defects of somatic\nhypermutation and class switching in alymphoplasia (aly) mutant mice","volume":"8","author":"Shinkura","year":"1996","journal-title":"Int. Immunol."},{"key":"2026090707075315700_cit37","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S1074-7613(01)00129-7","article-title":"Marginal\nzone and B1 B cells unite\nin the early response against T-independent blood-borne particulate\nantigens","volume":"14","author":"Martin","year":"2001","journal-title":"Immunity"},{"key":"2026090707075315700_cit38","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade1413","article-title":"T-independent responses\nto polysaccharides in humans mobilize marginal zone B cells prediversified\nagainst gut bacterial antigens","volume":"8","author":"Weller","year":"2023","journal-title":"Sci. Immunol."},{"key":"2026090707075315700_cit39","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1016\/j.molimm.2008.01.020","article-title":"Thymus-independent\ntype 2 antigen\ninduces a long-term IgG-related network memory","volume":"45","author":"Lange","year":"2008","journal-title":"Mol. Immunol."},{"key":"2026090707075315700_cit40","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1084\/jem.191.9.1477","article-title":"Alymphoplasia (aly)-type\nnuclear\nfactor kappaB-inducing kinase (NIK) causes defects in secondary lymphoid\ntissue chemokine receptor signaling and homing of peritoneal cells\nto the gut-associated lymphatic tissue system","volume":"191","author":"Fagarasan","year":"2000","journal-title":"J. Exp Med."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6c00395","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/9\/4673\/66385372\/acs.molpharmaceut.6c00395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/9\/4673\/66385372\/acs.molpharmaceut.6c00395.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:29:41Z","timestamp":1788780581000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/9\/4673\/5242828\/A-Cosmetic-Product-Containing-PEG-Derivatives"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,8,4]]},"published-print":{"date-parts":[[2026,9,7]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00395","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}